Epidural volume extension is a technical modification of the combined spinal epidural block. It involves the epidural injection of normal saline or a small volume of local anaesthetic after an intrathecal injection, aiming to augment the post-spinal sensory level. Although the consequent sensory block augmentation has been adequately documented, the probable factors influencing epidural volume extension and its implications for clinical practice are not well defined. This article reviews published literature relating to the probable factors affecting epidural volume extension, its clinical implications, case reports of its successful clinical application and summarises its unexplored effects.
In the last decade or so, central neuraxial blockade has undergone significant modification of the techniques, as well as the drugs available for neuraxial injection. Subarachnoid and epidural block can be performed as either a single shot or continuous technique, while a combination of both is practised as the popular combined spinal epidural (CSE) block. A further clinical modification of the CSE technique is epidural volume extension (EVE).
Epidural volume extension was initially defined as an epidural injection of local anaesthetic or normal saline administered soon after an intrathecal injection, with the objective of rapidly increasing the post-spinal sensory level 1, 2 . More recently in clinical practice, EVE has come to imply the injection of normal saline only 3 .
We undertook this review of EVE to explore existing evidence for the probable factors affecting it and its utility in clinical practice. Another aim was to review case reports or series describing successful use of lower intrathecal doses by means of EVE.
For the purpose of discussing the evidence regarding EVE, the technique is taken to include injections of normal saline or local anaesthetic as originally described.
METHODOLOGY
Studies published in the English language comparing block characteristics (sensory or motor blockade, or both; with or without hypotension) following EVE and any other central neuraxial technique (single shot subarachnoid or combined spinal epidural) were considered for inclusion. The MEDLINE database was used to identify studies using the search terms 'epidural volume extension', 'epidural volume expansion', 'modified combined spinal epidural' or 'combined spinal epidural' and 'sensory block level'. Three of the reviewers independently assessed the titles and abstracts of all eligible studies (total of 172 abstracts using the above keywords) to determine if they met the inclusion criteria. A total of 15 studies met these criteria. Data extracted from full texts of the included studies covered the number and characteristics of patients, the characteristics of intrathecal and epidural injections, patient position during the intrathecal block, the time lag before the performance of EVE following the intrathecal injection, the maximum sensory and motor blockade, the EVE-induced rise in sensory block, and the occurrence of hypotension (Tables 1 and 2) 1, 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] .
To explore the published cases of successful use of lower intrathecal doses by means of EVE, case reports using deliberately inadequate doses of intrathecal local anaesthetic followed by epidural boluses of normal saline or local anaesthetic titrated to achieve an adequate block were included. The MEDLINE database was searched using the keywords: 'epidural volume extension' and 'case reports'; 'combined spinal epidural' and 'lowered intrathecal dose'; and also 'sequential combined spinal epidural'. Data extracted from the full text of the 11 relevant case studies (Table 3 ) [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] included characteristics of the patient, the intrathecal and epidural injections, the sensory block achieved, the occurrence of hypotension and the nature of surgery.
MECHANISMS OF ACTION OF EVE
Prior to discussing the results of the search conducted for this review, the mechanisms of action of EVE are briefly enumerated. Mechanisms ascribed to explain the rapid extension of sensory block that occurs with EVE include a 'volume effect', 'drug effect' and augmentation of a pre-existing area of subclinical analgesia.
Volume effect or thecal compression
The most commonly extended explanation for EVE is thecal compression due to the volume effect on consequent epidural injection of fluid 4 . This thecal compression causes cephalad shift of local anaesthetic within the cerebrospinal fluid, raising the level of sensory block. Imaging studies document thecal compression following EVE and several studies demonstrate an increase in post-spinal sensory block following epidural injection of normal saline 1,2,4,5 .
Takiguchi et al demonstrated thecal compression following EVE in a myelographic study conducted in healthy volunteers in an upright (45 degree) posture 27 . The upper level of the contrast medium in the subarachnoid space was observed to rise progressively when 5 ml aliquots of normal saline were injected into the epidural space. The diameter of the subarachnoid space decreased to 40% of initial diameter after the first aliquot and to 25% following the second aliquot. With the third and fourth aliquots the diameter of subarachnoid space decreased further but the maximum decrement occurred after the first injection. Epidural injections of 5 ml, 10 ml and 15 ml normal saline caused a significant reduction in the lumbosacral cerebrospinal fluid volume visualised using magnetic resonance imaging 28 . The reduction increased with an increasing volume of epidural injectate, being 2.0±1.0 ml after a 5 ml injection (n=10), 4.4±1.4 ml after 10 ml (n=9) and 7.2±2.6 ml after a 15 ml injection (n=9).
It can be concluded that thecal compression or a volume effect to explain block augmentation with EVE is not merely a hypothesis, but is supported by imaging and clinical studies.
Drug effect
When local anaesthetic is used for EVE, an additional increase in the sensory block level over and above that produced by normal saline injection has been noted 1 . This finding led to an additional drug effect being suggested for EVE 1 but the evidence for this is contradictory 1,2,5 .
Stienstra and colleagues 1 reported a significantly greater increase in the post-spinal sensory block level following epidural injection of 10 ml plain bupivacaine (0.5%) compared to an equivalent volume of normal saline (4.8±1.6 segments vs 2.0±2.0 segments), but Choi and colleagues 5 found no significant difference in block level produced by epidural injections of 10 ml of normal saline or bupivacaine (0.25%) for EVE. No additional block augmentation was noted in another study comparing 5 or 10 ml of normal saline with equal volumes of bupivacaine, i.e. 5 ml (0.5%) or 10 ml (0.25%) 2 .
It appears from these studies that local anaesthetic may exert an additional drug effect when used in larger doses (e.g. 10 ml of 0.5%) 1 and that the effect may be absent with smaller epidural doses, irrespective of the volume (e.g. 5 ml of 0.5% or 10 ml of 0.25%) 2,5 . To conclude, thecal compression is considered the major contributor to block ascent with EVE along with an additional dose-dependent drug effect.
Subclinical analgesia
When local anaesthetic is used for the epidural injection, another hypothesis has been postulated to explain the phenomenon of EVE 29 . Following the intrathecal injection there is a pre-existing area of subclinical analgesia cranial to the spinal segment corresponding with the maximum level of spinal block. Herein, a subclinical concentration of local anaesthetic is present and this area can be converted to complete analgesia, providing a rapid increase in sensory level, by using an otherwise inadequate dose of epidural local anaesthetic 29 .
FACTORS AFFECTING EVE
The studies exploring EVE are heterogeneous with regard to patient population and position, intrathecal drug, and timing and nature of the epidural injection (Tables 1 and 2) , despite all being factors that affect intrathecal drug distribution during spinal blockade. The following section attempts to draw inferences from existing literature regarding possible factors that may affect the results of EVE. 
Time from intrathecal to epidural injection
Studies conducted in non-obstetric patients indicate that the success of EVE may depend on the time lag between intrathecal injection and its performance 12, 30 . Trautman and coworkers 30 injected 10 ml of epidural normal saline after two-segment regression of spinal block and noted a paradoxical decrease in the duration of spinal anaesthesia. Mardirosoff and colleagues 12 noted that EVE performed 20 minutes after intrathecal injection failed to produce any significant increase in the sensory level. However, EVE five minutes after the intrathecal injection produced a significantly higher sensory block ( Table 2) .
While the effect and utility of EVE appears to be influenced by the time between the intrathecal and epidural injection, the optimal time for its performance cannot be deduced from the available evidence. It appears prudent to perform it soon after the intrathecal injection, before the intrathecal drug is fully distributed and fixed within the neuraxial tissues.
Volume of the epidural injectate used for EVE
Imaging studies indicate that the degree of thecal compression is directly proportional to the volume injected into the epidural space 27, 28 , with larger epidural volumes producing greater compression. If so, the extent of block augmentation with EVE should be a function of the volume used for epidural injection. However, existing literature is inconclusive on the volume dependency of EVE.
In almost all the trials on EVE conducted in nonobstetric patients the volume of epidural injectate was 10 ml (Table 2) , while in obstetric patients it ranged from 5 to 10 ml (Table 1 ). Higher volumes of 15 ml and 20 ml were evaluated in non-obstetric patients in a recent study 9 .
Two studies evaluated the effect of various volumes of epidural injectate for EVE, both conducted in non-obstetric patients 2, 13 . The comparison of 5, 10, 15 and 20 ml of normal saline, following intrathecal injection of 10 mg isobaric bupivacaine, noted similar maximum block height but a significantly longer duration of sensory block with higher volumes 13 . This study was powered to detect a difference of one segment in the sensory block level. The other study also found no significant difference in the block height following injections of 5 or 10 ml of epidural injectate 2 , but this study was not powered to detect differences in this endpoint.
Although suggested by imaging studies, there are no clinical data to support greater sensory block augmentation from increasing volumes of epidural solution. Further evidence about volume effect is required and the minimum effective volume during EVE necessary to achieve block ascent needs to be investigated.
EVE, intrathecal drug baricity and patient position
The interplay between the baricity of the intrathecal drug and gravity is an important determinant of the extent of subarachnoid block 31 . If a hyperbaric local anaesthetic is injected intrathecally with the patient in the sitting position it tends to pool caudally 32 . Lower levels of sensory block have been noted with hyperbaric local anaesthetic when injected with the patient in the sitting position compared to the lateral position [33] [34] [35] . Also, since the epidural pressure in the sitting position is greater than in the lateral, when an isobaric (effectively slightly hypobaric) drug is injected, the effect of EVE may well be greater in the sitting position because there is no gravity-dependent limitation of its cephalad spread.
Whether the extent of increase in sensory level due to EVE also depends on the initial interplay between intrathecal drug baricity and patient position has not been specifically evaluated, but inferences can be drawn regarding its role.
In obstetric patients in whom intrathecal hyperbaric bupivacaine was injected in the sitting position, EVE failed to increase the sensory block compared with CSE and single shot subarachnoid block 10 . In contrast, in another study it produced successful block augmentation of intrathecal hyperbaric bupivacaine injected in the sitting position 4 . Of note, the EVE volume was double (10 vs 5 ml).
In non-obstetric patients, EVE failed to decrease the intrathecal dose requirement of hyperbaric bupivacaine injected in the sitting position 15 . When applied to isobaric bupivacaine injected in the sitting position, EVE produced successful block augmentation 1, 2, 15 . In contrast, Yamazaki et al 14 found that EVE significantly increased the sensory level of block from hyperbaric tetracaine. However, in that study the block was performed with patients in the lateral position. Thus, in both obstetric and non-obstetric patients, there is evidence to show the failure of EVE if applied to hyperbaric bupivacaine injected intrathecally in the sitting position but not if applied to plain bupivacaine. However, to conclusively prove the relevance of the interaction between drug baricity and patient positioning, a trial comparing EVE after intrathecal hyperbaric and plain bupivacaine with patients injected in the same position is required. 
CLINICAL IMPLICATIONS OF EVE
Even though several trials have been conducted, the clinical utility of EVE needs further critical examination. Is the sensory block augmentation it produces merely an epiphenomenon 3 or is there evidence for a role in clinical practice?
Raising the sensory block level
There are several trials exploring the consequences of EVE on sensory block level in obstetric as well as non-obstetric patients (Tables 1 and 2) . In trials conducted on non-obstetric patients, almost all report significantly higher sensory blocks after EVE, with up to a three segment increase in mean values 1, 2, 13, 14 . In obstetric patients scheduled for caesarean section, EVE has succeeded 4 or failed 5, 10, 11 to augment the maximum sensory block. The failure of EVE may be attributed to a prolonged time interval between intrathecal and epidural injection 5,12 , or to the interplay of gravity and hyperbaric intrathecal drug solutions [10] [11] .
Trials allowing variations in the intrathecal drug dose within the group 6, 15 or between groups 7-9 are not suited to derive conclusions about the effect of EVE on sensory block level. The variations in block characteristics found probably result from differences in intrathecal doses rather than EVE.
In summary, these studies suggest that EVE does raise the sensory block level provided factors that retard block enhancement are avoided. The effect of EVE may be used in clinical practice as a rescue strategy to rapidly increase the block in cases of an inadequate sensory level. However, since EVE is a time-dependent phenomenon, it cannot be expected to yield positive results if used late in the course of block development. Although the precise time after intrathecal drug deposition up to which EVE using normal saline can be effective is unknown, it appears of limited utility once the maximum block height has been reached 30 or the drug is fixed in the intrathecal compartment 12 .
Decreasing the intrathecal drug dose
In clinical practice EVE is often used to allow a use of a reduced dose of intrathecal drug. Despite the popularity of this application, there are only two studies dealing with the effect of EVE on intrathecal dose 6, 15 .
Dose reduction by EVE has been evaluated in non-obstetric patients given hyperbaric or plain bupivacaine. While a significant decrease in the minimum effective dose of plain bupivacaine was seen 15 , no dose-sparing effect was found for hyperbaric bupivacaine (probably because the block was conducted in the sitting position). In obstetric patients, EVE had no effect on the median effective dose of bupivacaine required for caesarean section (5.1 vs 6.1 mg) 6 . A possible explanation is that the volume of normal saline used was only 7 ml and the drug, hyperbaric bupivacaine, was administered with the patient in the sitting position.
Thus, the failure to observe a dose-sparing effect of EVE in some studies may have resulted from methodological differences and a role for EVE in reducing intrathecal dose requirement may exist.
HAEMODYNAMIC STABILITY
Improvement of post-spinal haemodynamic stability is a widely accepted reason for using EVE, whereby an injection of a small intrathecal dose is followed by the epidural injection of normal saline or a small volume of local anaesthetic.
Reduction of intrathecal doses during spinal block has been observed to minimise the incidence of post-spinal adverse effects, primarily hypotension 36, 37 . While comparing intrathecal hyperbaric bupivacaine in doses of 7, 8 and 9 mg a significant decrease in the incidence of hypotension was noted when the dose was reduced from 9 to 7 mg, although there was no difference in vasopressor use 38 . The incidence of post-spinal hypotension after 7 and 10 mg of bupivacaine has been compared 39 . The relative risk for a 20% decrease in systolic blood pressure with the smaller dose was 1.6 (95% confidence interval [CI] 1.1 to 1.24). Most recently, a meta-analysis of low-dose spinal anaesthesia concluded a lower risk of hypotension (RR 0.78, 95% CI 0.65 to 0.93) when low doses of spinal bupivacaine (≤8 mg) are used for caesarean section 40 .
Despite being used clinically with the intention of providing greater haemodynamic stability, none of the trials evaluating EVE have used hypotension as the primary outcome measure. Of the few trials noting the incidence of hypotension following EVE as a secondary or tertiary observation 1,4-6,10 , none report a significant decrease in incidence of hypotension (Table 1) .
Thus, the clinical experience of greater haemodynamic stability seen with EVE may be secondary to the deliberate decrease in intrathecal local anaesthetic dose, rather than an effect of EVE per se.
EFFICACY OF BLOCK
A clinical limitation of using decreased intrathecal doses is the increased need for intraoperative analgesic supplementation because of either intraoperative pain or failure to achieve a predetermined level 40 . Meta-analysis found reduced intrathecal doses of bupivacaine to be associated with a higher risk of intraoperative analgesic supplementation (RR 3.76, 95% CI 2.38 to 5.92). EVE using reduced intrathecal doses also results in increased incidence of intraoperative analgesic supplementation 9 and shorter duration of motor blockade 7,8 as compared to higher intrathecal doses used without EVE.
The primary aim of using EVE is to use reduced intrathecal doses. The technique should thus be practiced only with an indwelling epidural catheter inserted as part of the central block procedure. Performing EVE through the Tuohy needle, without epidural catheter insertion, limits the utility of EVE.
CASE STuDIES uSING EVE
In more recent literature, authors using local anaesthetic epidural injection following a small intrathecal dose have termed this approach "sequential combined spinal epidural" 3, 41 , while EVE has come to imply an epidural injection of normal saline. This is somewhat confusing because the term was first used in the 1980s to describe an approach in which low doses of intrathecal bupivacaine, insufficient to establish surgical anaesthesia, were administered with a much later injection of epidural local anaesthetic to extend the block. To review clinical case reports wherein EVE was used, we included cases in which EVE or sequential CSE was used following a low intrathecal dose (Table 3) [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] .
A distinction between sequential CSE and EVE using a local anaesthetic is the volume and timing of epidural injectates. When EVE is planned, being a time-dependent phenomenon, it is applied shortly after the intrathecal injection (Table 1 ). In contrast, in sequential CSE the local anaesthetic injections are given as incremental boluses at various times, irrespective of intrathecal drug fixation, until the required sensory level is achieved [16] [17] [18] 23 . While trials exploring EVE with local anaesthetics have mostly used volumes of 5 to 10 ml (Tables 1 and 2 ), in sequential blocks smaller aliquots of 1 to 4 ml have been used ( Table 3 ).
The practice of EVE or sequential CSE appears limited largely to patients with cardiovascular disease, especially among obstetric subjects (Table 3) . This may stem from the fact that minimising the intrathecal dose to avoid post-spinal hypotension in obstetric patients is of greater clinical concern than in nonobstetric patients, owing to the fetal concerns. The dose of intrathecal bupivacaine in the case studies ranges from 2.5 mg to 9 mg (Table 3) .
In most of the reported cases, small epidural volumes of local anaesthetic (1 to 4 ml) were used, while normal saline was injected in only four of the 14 cases (Table 3 ). The primary objective of the technique was to minimise post-spinal adverse effects, primarily hypotension, and this aim was met in almost all of the cases (Table 3) . Interestingly, almost all the reported cases used hyperbaric bupivacaine with the patient injected in the sitting position, but still noted successful block augmentation. This may have been due to the use of intrathecal opioids that reduce the hyperbaricity of the intrathecal bupivacaine, and titrated use of local anaesthetic for the epidural injections.
uNEXPLORED ASPECTS OF EVE
To investigate the unexplored aspects of EVE we have mentioned, future prospective randomised trials are required.
Patient height and EVE
Although we have enumerated certain factors that appear to influence EVE, there could be other factors not previously investigated that affect characteristics of subarachnoid or epidural blocks. Although controversial, there is some evidence for an influence of patient height on intrathecal drug spread 31 . This possible association could be explored for EVE.
Pregnancy and EVE
Pregnancy decreases intrathecal dose requirement 42 . One postulated reason for this decrease is the epidural venous engorgement that results from uterine enlargement and consequent vena caval compression. A consequence is thecal compression, displacing the cerebrospinal fluid within the subarachnoid space and causing either a decrease in the requirement for the intrathecal drug 42 or an increase in its intrathecal spread 31 . A procedure such as EVE, which further causes thecal compression, may produce greater compression compared to non-pregnant subjects. Active labour, by causing uterine contractions, may further increase epidural space pressure and enhance the effect of EVE. There are no trials addressing the differences in EVE between pregnant and nonpregnant patients but all case scenarios using EVE or a sequential CSE technique, employing reduced intrathecal doses, involve obstetric anaesthesia (Table  3) .
Motor block and EVE
Loubert et al 9 observed less motor block in obstetric patients when using 7.5 mg bupivacaine with EVE compared to 10 mg without EVE. Reduction of the intrathecal dose was ruled out as the possible cause, since 7.5 mg bupivacaine without EVE produced similar motor block to the 10 mg dose. It was hypothesised that the epidural injection in the sitting position may have accelerated the spread of hyperbaric bupivacaine into sacral segments, wherein it was trapped due to the curvature of the spine in the supine position. As sacral roots do not contribute significantly to motor function of the lower limb, this compromised motor block, which is not very important for obstetric surgery. Besides this trial, no other has critically evaluated motor block following EVE. Although the study by Lew et al 8 in obstetric patients is often quoted to support less motor block with EVE, this compared a reduced intrathecal dose (6 mg) with EVE and a higher dose without EVE (9 mg). The absence of a control group makes such a conclusion invalid.
EVE causes intrathecal drug to ascend cephalad over a larger distribution which might decrease the concentration of the local anaesthetic within the subarachnoid space. Motor block is known to be affected adversely by decreasing intrathecal drug concentration 43 . Whether this is a contributing factor, EVE needs to be considered in further trials. A propensity for decreased motor block could be an advantage for specific operations such as ambulatory anaesthesia, whereas reducing motor block during surgery might be undesirable during knee or hip surgery.
Other roles for EVE
Epidural injections of saline and blood are known therapies for post-spinal low-pressure effects such as post-dural puncture headache and hearing loss 44, 45 . use of EVE and continued postoperative epidural injections for postoperative analgesia was associated with a decrease in postoperative hearing loss 46 . Whether raising intrathecal pressure with EVE prevents post-spinal low-pressure adverse effects is another area of possible research.
CONCLuSION
EVE-induced sensory block augmentation has adequate documentation and in clinical practice is mostly used following deliberate administration of a reduced or inadequate dose of intrathecal local anaesthetic to provide post-spinal haemodynamic stability. The technique of EVE as presently defined, i.e. based on injection of normal saline only, appears more as an application to investigational studies than of value in clinical practice. Greater clinical application of sequential CSE anaesthesia is seen, this being a modification wherein titrated volumes of epidural local anaesthetic are used. Consistent with the knowledge that several factors affect block characteristics, considerations relevant to effective use of EVE need further exploration, especially the optimal injectate volume and timing for EVE. Most studies noting a failure of EVE to produce an effect are confounded by these factors. Research may also identify other clinical reasons, such as altered motor block characteristics or decreased post-spinal low-pressure adverse effects, to justify a greater role of EVE in clinical practice. until such time, the use of EVE is likely to continue, despite several unanswered questions and contradictory clinical findings regarding its benefit.
